Levi & Korsinsky Notifies Shareholders of Merck & Co., Inc.(MRK) of a Class Action Lawsuit and an Upcoming Deadline
Portfolio Pulse from
Levi & Korsinsky law firm has filed a class action securities lawsuit against Merck & Co., alleging securities fraud related to Gardasil sales projections in China. The lawsuit claims Merck misrepresented expected revenue of $11 billion by 2030, with the stock dropping over 9% after announcing it would cease Gardasil shipments to China midyear due to lower-than-expected demand.
March 29, 2025 | 10:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Merck's stock price could be impacted by the class action lawsuit alleging securities fraud, with potential financial penalties and investor confidence erosion.
The lawsuit directly targets Merck's representations about Gardasil sales in China, which led to a significant stock price drop. Legal proceedings and potential financial settlements could negatively impact investor sentiment and stock performance.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100